Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 106 articles: HTML format

Single Articles

March 2021
1. FABRIS E, Korjian S, Coller B, Ten Berg JM, et al
   Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.
   Thromb Haemost. 2021 Mar 7. doi: 10.1055/a-1414-5009.
   PubMed     Abstract available
   
   
   January 2021
2. GUEDENEY P, Collet JP
   Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late Management.
   Thromb Haemost. 2021 Jan 27. doi: 10.1055/s-0040-1722188.
   PubMed     Abstract available
   
   
   
3. HENNING C, Branopolski A, Follert P, Lewandowska O, et al
   Endothelial beta1 Integrin-Mediated Adaptation to Myocardial Ischemia.
   Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1721505.
   PubMed     Abstract available
   
   
   
4. STOJKOVIC S, Wadowski PP, Haider P, Weikert C, et al
   Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome.
   Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1722226.
   PubMed     Abstract available
   
   
   December 2020
5. AZNAOURIDIS K, Tselegkidi ME, Kanakakis I, Alexopoulos D, et al
   Dual Antithrombotic Therapy in Atrial Fibrillation Patients undergoing Percutaneous Coronary Angioplasty: The Impact of Bleeding Risk Score on Outcome.
   Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721777.
   PubMed    
   
   
   
6. ARROYO AB, Aguila S, Fernandez-Perez MP, DE Los Reyes-Garcia AM, et al
   miR-146a in cardiovascular diseases and sepsis: an additional burden in the inflammatory balance?
   Thromb Haemost. 2020 Dec 22. doi: 10.1055/a-1342-3648.
   PubMed     Abstract available
   
   
   
7. CAO YX, Zhang HW, Jin JL, Liu HH, et al
   Lipoprotein(a) and cardiovascular outcomes in patients with previous myocardial infarction: a prospective cohort study.
   Thromb Haemost. 2020 Dec 18. doi: 10.1055/a-1340-2109.
   PubMed     Abstract available
   
   
   
8. KAZEM N, Hofer F, Koller L, Hammer A, et al
   The age-specific impact of cellular immunity on long-term outcome after acute coronary syndrome.
   Thromb Haemost. 2020 Dec 18. doi: 10.1055/a-1340-2055.
   PubMed     Abstract available
   
   
   
9. FABER J, Hvas AM, Kristensen SD, Grove EL, et al
   Immature Platelets and Risk of Cardiovascular Events among Patients with Ischemic Heart Disease: A Systematic Review.
   Thromb Haemost. 2020 Dec 10. doi: 10.1055/s-0040-1721386.
   PubMed     Abstract available
   
   
   
10. LAINE M, Panagides V, Frere C, Cuisset T, et al
    On-ticagrelor platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Thromb Haemost. 2020 Dec 1. doi: 10.1055/a-1326-5110.
    PubMed     Abstract available
    
    
    November 2020
11. MONTALTO C, Ferlini M, Casula M, Mandurino-Mirizzi A, et al
    DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/s-0040-1721145.
    PubMed    
    
    
    
12. ZOLLER BA, Svensson P, Huang W, Ji J, et al
    Reactome pathway analysis of venous thromboembolism, peripheral artery disease, stroke, and coronary artery.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/a-1315-2307.
    PubMed     Abstract available
    
    
    
13. KIM HK, Tantry US, Smith SC Jr, Jeong MH, et al
    The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease.
    Thromb Haemost. 2020 Nov 10. doi: 10.1055/s-0040-1718729.
    PubMed     Abstract available
    
    
    October 2020
14. ZHENG YY, Wu TT, Gao Y, Guo QQ, et al
    A Novel ABC Score Predicts Mortality in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Who underwent Percutaneous Coronary Intervention.
    Thromb Haemost. 2020 Oct 31. doi: 10.1055/s-0040-1718411.
    PubMed     Abstract available
    
    
    
15. GENCER S, Lacy M, Atzler D, van der Vorst EPC, et al
    Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19.
    Thromb Haemost. 2020 Oct 29. doi: 10.1055/s-0040-1718735.
    PubMed     Abstract available
    
    
    
16. GUILLET B, Cayla G, Lebreton A, Trillot N, et al
    Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry.
    Thromb Haemost. 2020 Oct 24. doi: 10.1055/s-0040-1718410.
    PubMed     Abstract available
    
    
    September 2020
17. GEROTZIAFAS GT, Catalano M, Colgan MP, Pecsvarady Z, et al
    Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.
    Thromb Haemost. 2020 Sep 13. doi: 10.1055/s-0040-1715798.
    PubMed     Abstract available
    
    
    
18. VAN PARIDON PCS, Panova-Noeva M, van Oerle R, Schulz A, et al
    Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.
    Thromb Haemost. 2020 Sep 2. doi: 10.1055/s-0040-1715897.
    PubMed     Abstract available
    
    
    
19. HSU LW, Chen PW, Chang WT, Lee WH, et al
    The Role of ROCK in Platelet-Monocyte Collaborative Induction of Thromboinflammation during Acute Coronary Syndrome.
    Thromb Haemost. 2020 Sep 2. doi: 10.1055/s-0040-1714278.
    PubMed     Abstract available
    
    
    August 2020
20. MANDROLA JM, Kaul S, Foy A
    Lessons Learnt from Recent Trials in Ischemic Heart Disease.
    Thromb Haemost. 2020 Aug 30. doi: 10.1055/s-0040-1715830.
    PubMed     Abstract available
    
    
    
21. XIN L, Sun S, Wang J, Lu W, et al
    Dipeptidyl Peptidase 4 Inhibitors and Venous Thromboembolism Risk in Patients with Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials.
    Thromb Haemost. 2020 Aug 9. doi: 10.1055/s-0040-1715444.
    PubMed    
    
    
    July 2020
22. FERNANDO H, McFadyen JD, Palasubramaniam J, Shaw J, et al
    Antithrombotic Therapy in Myocardial Infarction: Historic Perils and Current Challenges-A 70-Year Journey.
    Thromb Haemost. 2020 Jul 24. doi: 10.1055/s-0040-1714212.
    PubMed     Abstract available
    
    
    
23. LIU Z, Tian R, Wang Y, Chen Q, et al
    Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes.
    Thromb Haemost. 2020 Jul 15. doi: 10.1055/s-0040-1713375.
    PubMed     Abstract available
    
    
    June 2020
24. WINTHER-LARSEN A, Christiansen MK, Larsen SB, Nyegaard M, et al
    The ABO Locus is Associated with Increased Fibrin Network Formation in Patients with Stable Coronary Artery Disease.
    Thromb Haemost. 2020 Jun 30. doi: 10.1055/s-0040-1713753.
    PubMed     Abstract available
    
    
    May 2020
25. PURAM RV, Erdil RM, Weber BN, Knelson EH, et al
    Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies.
    Thromb Haemost. 2020 May 29. doi: 10.1055/s-0040-1712458.
    PubMed    
    
    
    
26. DAI C, Chen Z, Fu J, Qian J, et al
    Cilostazol for Chinese Patients with Aspirin Intolerance after Coronary Drug-Eluting Stent Implantation.
    Thromb Haemost. 2020;120:857-865.
    PubMed     Abstract available
    
    
    April 2020
27. D'ALESSANDRO E, Becker C, Bergmeier W, Bode C, et al
    Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis.
    Thromb Haemost. 2020;120:538-564.
    PubMed     Abstract available
    
    
    March 2020
28. PANDEY AK, Xu K, Zhang L, Gupta S, et al
    Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Thromb Haemost. 2020;120:484-494.
    PubMed     Abstract available
    
    
    
29. RAMOTOWSKI B, Gurbel PA, Tantry U, Bracha JS, et al
    Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox Study.
    Thromb Haemost. 2020;120:449-456.
    PubMed     Abstract available
    
    
    February 2020
30. GOROG DA, Geisler T
    Platelet Inhibition in Acute Coronary Syndrome and Percutaneous Coronary Intervention: Insights from the Past and Present.
    Thromb Haemost. 2020 Feb 19. doi: 10.1055/s-0040-1702920.
    PubMed     Abstract available
    
    
    
31. CAPODANNO D, Angiolillo DJ
    Pooling the Evidence at the Patient Level: End of the Bivalirudin Saga?
    Thromb Haemost. 2020;120:191-193.
    PubMed    
    
    
    
32. KNOPP T, Karbach S, Wenzel P
    Myeloid Cells to the Rescue: Improving Thrombus Resolution.
    Thromb Haemost. 2020;120:197-198.
    PubMed    
    
    
    January 2020
33. SUMAYA W, Wallentin L, James SK, Siegbahn A, et al
    Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study.
    Thromb Haemost. 2020 Jan 23. doi: 10.1055/s-0039-1701011.
    PubMed     Abstract available
    
    
    
34. AKHMEDOV A, Montecucco F, Costantino S, Vdovenko D, et al
    Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3.
    Thromb Haemost. 2020;120:168-180.
    PubMed     Abstract available
    
    
    
35. TAVENIER AH, Hermanides RS, Fabris E, Lapostolle F, et al
    Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial.
    Thromb Haemost. 2020;120:65-74.
    PubMed     Abstract available
    
    
    
36. GOROG DA
    Understanding the Effects of NOAC Combined with Antiplatelet Therapy on Clot Kinetics.
    Thromb Haemost. 2020;120:8-10.
    PubMed    
    
    
    December 2019
37. DE CATERINA R, Aimo A, Ridker PM
    Aspirin Therapy for Primary Prevention: The Case for Continuing Prescribing to Patients at High Cardiovascular Risk-A Review.
    Thromb Haemost. 2019 Dec 30. doi: 10.1055/s-0039-3400294.
    PubMed     Abstract available
    
    
    
38. CARLSON DS, Bartholomew JR, Gomes MP, McCrae KR, et al
    Outcomes of Cardiovascular Surgery Utilizing Heparin versus Direct Thrombin Inhibitors in Cardiopulmonary Bypass in Patients with Previously Diagnosed HIT.
    Thromb Haemost. 2019 Dec 30. doi: 10.1055/s-0039-3401825.
    PubMed     Abstract available
    
    
    
39. BIKDELI B, McAndrew T, Crowley A, Chen S, et al
    Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin versus Heparin in Acute Myocardial Infarction: Rationale and Methodology.
    Thromb Haemost. 2019 Dec 9. doi: 10.1055/s-0039-1700872.
    PubMed     Abstract available
    
    
    November 2019
40. NEERGAARD-PETERSEN S, Larsen SB, Grove EL, Kristensen SD, et al
    Imbalance between Fibrin Clot Formation and Fibrinolysis Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
    Thromb Haemost. 2019 Nov 16. doi: 10.1055/s-0039-1700873.
    PubMed     Abstract available
    
    
    
41. GAO J, Liu J, Zhang Y, Guan B, et al
    PBMCs-Derived microRNA Signature as a Prethrombotic Status Discriminator in Stable Coronary Artery Disease.
    Thromb Haemost. 2019 Nov 12. doi: 10.1055/s-0039-1700518.
    PubMed     Abstract available
    
    
    October 2019
42. SCHROR K, Kristensen SD, Storey RF, Verheugt FWA, et al
    Aspirin and Primary Prevention in Patients with Diabetes-A Critical Evaluation of Available Randomized Trials and Meta-Analyses.
    Thromb Haemost. 2019;19:1573-1582.
    PubMed     Abstract available
    
    
    
43. VOGEL B, Chandrasekhar J, Baber U, Mastoris I, et al
    Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry.
    Thromb Haemost. 2019;19:1704-1711.
    PubMed     Abstract available
    
    
    September 2019
44. SCHUPKE S, Hein-Rothweiler R, Mayer K, Janisch M, et al
    Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER Trial.
    Thromb Haemost. 2019;119:1539-1545.
    PubMed     Abstract available
    
    
    August 2019
45. FRANCHI F, Rollini F, Garcia E, Rivas Rios J, et al
    Effects of Edoxaban on the Cellular and Protein Phase of Coagulation in Patients with Coronary Artery Disease on Dual Antiplatelet Therapy with Aspirin and Clopidogrel: Results of the EDOX-APT Study.
    Thromb Haemost. 2019 Aug 30. doi: 10.1055/s-0039-1695772.
    PubMed     Abstract available
    
    
    
46. ADATIA K, Farag MF, Gue YX, Srinivasan M, et al
    Relationship of Platelet Reactivity and Inflammatory Markers to Recurrent Adverse Events in Patients with ST-Elevation Myocardial Infarction.
    Thromb Haemost. 2019 Aug 22. doi: 10.1055/s-0039-1695007.
    PubMed     Abstract available
    
    
    
47. PATTI G, Di Martino G, Ricci F, Renda G, et al
    Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study.
    Thromb Haemost. 2019 Aug 20. doi: 10.1055/s-0039-1694969.
    PubMed     Abstract available
    
    
    
48. STOJKOVIC S, Nossent AY, Haller P, Jager B, et al
    MicroRNAs as Regulators and Biomarkers of Platelet Function and Activity in Coronary Artery Disease.
    Thromb Haemost. 2019 Aug 17. doi: 10.1055/s-0039-1693702.
    PubMed     Abstract available
    
    
    July 2019
49. KAIKITA K, Hosokawa K, Dahlen JR, Tsujita K, et al
    Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease.
    Thromb Haemost. 2019 Jul 22. doi: 10.1055/s-0039-1693411.
    PubMed     Abstract available
    
    
    
50. KOENEN RR
    Lysophosphatidylcholine in Platelet Microvesicles: The Grease for Cardiovascular Disease.
    Thromb Haemost. 2019 Jul 2. doi: 10.1055/s-0039-1693024.
    PubMed    
    
    
    
51. ALEXOPOULOS D, Dragasis S, Kafkas N
    Loading with Oral P2Y12 Receptor Inhibitors: To Crush or Not to Crush?
    Thromb Haemost. 2019;119:1037-1047.
    PubMed     Abstract available
    
    
    
52. OLSSON LINDVALL M, Hansson L, Klasson S, Davila Lopez M, et al
    Hemostatic Genes Exhibit a High Degree of Allele-Specific Regulation in Liver.
    Thromb Haemost. 2019;119:1072-1083.
    PubMed     Abstract available
    
    
    June 2019
53. FIECHTER M, Haider A, Bengs S, Maredziak M, et al
    Sex Differences in the Association between Inflammation and Ischemic Heart Disease.
    Thromb Haemost. 2019 Jun 21. doi: 10.1055/s-0039-1692442.
    PubMed     Abstract available
    
    
    
54. GROSS L, Kupka D, Trenk D, Geisler T, et al
    Gender and Outcomes following Guided De-Escalation of Antiplatelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Gender Substudy.
    Thromb Haemost. 2019 Jun 21. doi: 10.1055/s-0039-1692441.
    PubMed     Abstract available
    
    
    
55. SEJRUP JK, Borvik T, Grimnes G, Isaksen T, et al
    Myocardial Infarction as a Transient Risk Factor for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study.
    Thromb Haemost. 2019 Jun 16. doi: 10.1055/s-0039-1692176.
    PubMed     Abstract available
    
    
    
56. KOMOSA A, Lesiak M, Krasinski Z, Grygier M, et al
    Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI: A Meta-Analysis.
    Thromb Haemost. 2019;119:1000-1020.
    PubMed     Abstract available
    
    
    May 2019
57. UBAID S, Ford TJ, Berry C, Murray HM, et al
    Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial.
    Thromb Haemost. 2019 May 26. doi: 10.1055/s-0039-1688789.
    PubMed     Abstract available
    
    
    
58. KANG J, Park KW, Ki YJ, Park J, et al
    Development and Validation of an Ischemic and Bleeding Risk Evaluation Tool in East Asian Patients Receiving Percutaneous Coronary Intervention.
    Thromb Haemost. 2019 May 12. doi: 10.1055/s-0039-1688792.
    PubMed     Abstract available
    
    
    March 2019
59. SUMAYA W, Geisler T, Kristensen SD, Storey RF, et al
    Dual Antiplatelet or Dual Antithrombotic Therapy for Secondary Prevention in High-Risk Patients with Stable Coronary Artery Disease?
    Thromb Haemost. 2019 Mar 5. doi: 10.1055/s-0039-1679903.
    PubMed     Abstract available
    
    
    
60. ZHENG YY, Wu TT, Chen Y, Hou XG, et al
    Gamma-Glutamyl Transferase-to-Platelet Ratio as a Novel Predictor of Long-Term Adverse Outcomes in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Thromb Haemost. 2019 Mar 1. doi: 10.1055/s-0039-1681103.
    PubMed     Abstract available
    
    
    February 2019
61. GENCER S, van der Vorst EPC, Aslani M, Weber C, et al
    Atypical Chemokine Receptors in Cardiovascular Disease.
    Thromb Haemost. 2019 Feb 4. doi: 10.1055/s-0038-1676988.
    PubMed     Abstract available
    
    
    
62. MARTINELLI N, Baroni M, Castagna A, Lunghi B, et al
    Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation.
    Thromb Haemost. 2019;119:192-202.
    PubMed     Abstract available
    
    
    January 2019
63. FREYNHOFER MK, Hein-Rothweiler R, Haller PM, Aradi D, et al
    Diurnal Variability of On-Treatment Platelet Reactivity in Clopidogrel versus Prasugrel Treated Acute Coronary Syndrome Patients: A Pre-Specified TROPICAL-ACS Sub-Study.
    Thromb Haemost. 2019 Jan 29. doi: 10.1055/s-0038-1677549.
    PubMed     Abstract available
    
    
    
64. KOH JS, Park Y, Ahn JH, Kang MG, et al
    Influence of Amlodipine on Haemostatic Measurements during Clopidogrel Treatment in Patients with Coronary Artery Disease.
    Thromb Haemost. 2019 Jan 4. doi: 10.1055/s-0038-1676795.
    PubMed     Abstract available
    
    
    
65. PACIULLO F, Momi S, Gresele P
    PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention.
    Thromb Haemost. 2019 Jan 3. doi: 10.1055/s-0038-1676863.
    PubMed     Abstract available
    
    
    
66. LEADER A, Ten Cate V, Ten Cate-Hoek AJ, Spectre G, et al
    Managing Anti-Platelet Therapy in Thrombocytopaenic Patients with Haematological Malignancy: A Multinational Clinical Vignette-Based Experiment.
    Thromb Haemost. 2019;119:163-174.
    PubMed     Abstract available
    
    
    
67. KANG J, Park KW, Palmerini T, Stone GW, et al
    Racial Differences in Ischaemia/Bleeding Risk Trade-Off during Anti-Platelet Therapy: Individual Patient Level Landmark Meta-Analysis from Seven RCTs.
    Thromb Haemost. 2019;119:149-162.
    PubMed     Abstract available
    
    
    December 2018
68. TSCHARRE M, Vogel B, Tentzeris I, Freynhofer MK, et al
    Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Dec 28. doi: 10.1055/s-0038-1676563.
    PubMed     Abstract available
    
    
    November 2018
69. SIKORA J, Niezgoda P, Baranska M, Buszko K, et al
    METoclopramide Administration as a Strategy to Overcome MORPHine-ticagrelOr Interaction in PatientS with Unstable Angina PectorIS-The METAMORPHOSIS Trial.
    Thromb Haemost. 2018 Nov 19. doi: 10.1055/s-0038-1675605.
    PubMed     Abstract available
    
    
    
70. STEENSIG K, Olesen KKW, Thim T, Nielsen JC, et al
    Should the Presence or Extent of Coronary Artery Disease be Quantified in the CHA2DS2-VASc Score in Atrial Fibrillation? A Report from the Western Denmark Heart Registry.
    Thromb Haemost. 2018 Nov 12. doi: 10.1055/s-0038-1675401.
    PubMed     Abstract available
    
    
    
71. KRUGER PC, Hirsh J, Bhagirath VC, Xu K, et al
    In Vitro Reversal of the Anti-Aggregant Effect of Ticagrelor Using Untreated Platelets.
    Thromb Haemost. 2018;118:1895-1901.
    PubMed     Abstract available
    
    
    October 2018
72. BADIMON L
    Monocyte-Platelet Complexes in Myocardial Infarction: Sub-Sets and Platelet-Derived Microvesicles Matter.
    Thromb Haemost. 2018 Oct 17. doi: 10.1055/s-0038-1675242.
    PubMed    
    
    
    
73. SORRENTINO S, Baber U, Claessen BE, Camaj A, et al
    Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Oct 12. doi: 10.1055/s-0038-1673687.
    PubMed     Abstract available
    
    
    
74. LOGUINOVA M, Pinegina N, Kogan V, Vagida M, et al
    Monocytes of Different Subsets in Complexes with Platelets in Patients with Myocardial Infarction.
    Thromb Haemost. 2018 Oct 9. doi: 10.1055/s-0038-1673342.
    PubMed     Abstract available
    
    
    September 2018
75. BONELLO L, Laine M, Lemesle G, Puymirat E, et al
    Meta-Analysis of Potent P2Y12-ADP Receptor Antagonist Therapy Compared to Clopidogrel Therapy in Acute Coronary Syndrome Patients with Chronic Kidney Disease.
    Thromb Haemost. 2018 Sep 20. doi: 10.1055/s-0038-1669426.
    PubMed     Abstract available
    
    
    
76. HANNAWI B, Hannawi Y, Kleiman NS
    Reticulated Platelets: Changing Focus from Basics to Outcomes.
    Thromb Haemost. 2018;118:1517-1527.
    PubMed     Abstract available
    
    
    August 2018
77. ZEYMER U, Schrage B, Westermann D
    Dual Pathway Inhibition with Low-Dose Direct Factor Xa Inhibition after Acute Coronary Syndromes-Why Is It Not Used in Clinical Practice?
    Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1668133.
    PubMed     Abstract available
    
    
    
78. KARHAUSEN JA, Qi W, Smeltz AM, Li YJ, et al
    Genome-Wide Association Study Links Receptor Tyrosine Kinase Inhibitor Sprouty 2 to Thrombocytopenia after Coronary Artery Bypass Surgery.
    Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1667199.
    PubMed     Abstract available
    
    
    
79. GROSS L, Trenk D, Jacobshagen C, Krieg A, et al
    Genotype-Phenotype Association and Impact on Outcomes following Guided De-Escalation of Anti-Platelet Treatment in Acute Coronary Syndrome Patients: The TROPICAL-ACS Genotyping Substudy.
    Thromb Haemost. 2018 Aug 13. doi: 10.1055/s-0038-1667337.
    PubMed     Abstract available
    
    
    
80. DUERSCHMIED D, Bode C
    Life-Saving Therapy versus Symptom Relief: Anti-Platelet Agents and Opioids in Coronary Intervention.
    Thromb Haemost. 2018;118:1350-1351.
    PubMed    
    
    
    July 2018
81. PEDICINO D, Giglio AF, Ruggio A, Massaro G, et al
    Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives.
    Thromb Haemost. 2018 Jul 10. doi: 10.1055/s-0038-1666860.
    PubMed     Abstract available
    
    
    June 2018
82. COELHO-LIMA J, Mohammed A, Cormack S, Jones S, et al
    Overcoming Heparin-Associated RT-qPCR Inhibition and Normalization Issues for microRNA Quantification in Patients with Acute Myocardial Infarction.
    Thromb Haemost. 2018 Jun 11. doi: 10.1055/s-0038-1660437.
    PubMed     Abstract available
    
    
    
83. ZAKAI NA, Judd SE, Kissela B, Howard G, et al
    Factor VIII, Protein C and Cardiovascular Disease Risk: The REasons for Geographic and Racial Differences in Stroke Study (REGARDS).
    Thromb Haemost. 2018 Jun 11. doi: 10.1055/s-0038-1655766.
    PubMed     Abstract available
    
    
    
84. VAN DER VORST EPC, Weber C, Donners MMPC
    A Disintegrin and Metalloproteases (ADAMs) in Cardiovascular, Metabolic and Inflammatory Diseases: Aspects for Theranostic Approaches.
    Thromb Haemost. 2018 Jun 6. doi: 10.1055/s-0038-1660479.
    PubMed     Abstract available
    
    
    
85. SUMAYA W, Parker WAE, Fretwell R, Hall IR, et al
    Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study).
    Thromb Haemost. 2018 Jun 6. doi: 10.1055/s-0038-1657768.
    PubMed     Abstract available
    
    
    
86. ALEXOPOULOS D, Xenogiannis I, Vlachakis P, Tantry U, et al
    Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention.
    Thromb Haemost. 2018 Jun 4. doi: 10.1055/s-0038-1649484.
    PubMed     Abstract available
    
    
    
87. CAPODANNO D, Greco A
    Risk Stratification for Bleeding in the Elderly with Acute Coronary Syndrome: Not So Simple.
    Thromb Haemost. 2018;118:949-952.
    PubMed    
    
    
    May 2018
88. BATUCA JR, Amaral MC, Favas C, Justino GC, et al
    Antibodies against HDL Components in Ischaemic Stroke and Coronary Artery Disease.
    Thromb Haemost. 2018 May 3. doi: 10.1055/s-0038-1645857.
    PubMed     Abstract available
    
    
    April 2018
89. PERTIWI KR, van der Wal AC, Pabittei DR, Mackaaij C, et al
    Neutrophil Extracellular Traps Participate in All Different Types of Thrombotic and Haemorrhagic Complications of Coronary Atherosclerosis.
    Thromb Haemost. 2018 Apr 19. doi: 10.1055/s-0038-1641749.
    PubMed     Abstract available
    
    
    
90. MAHLA E, Metzler H, Bornemann-Cimenti H, Prueller F, et al
    Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study.
    Thromb Haemost. 2018 Apr 6. doi: 10.1055/s-0038-1641153.
    PubMed     Abstract available
    
    
    
91. GARAY A, Ariza-Sole A, Formiga F, Raposeiras-Roubin S, et al
    Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry.
    Thromb Haemost. 2018 Apr 3. doi: 10.1055/s-0038-1635259.
    PubMed     Abstract available
    
    
    March 2018
92. CAMM AJ
    The Evolution of Antithrombotic Care in Cardiovascular Patients.
    Thromb Haemost. 2018 Mar 22. doi: 10.1055/s-0038-1626720.
    PubMed    
    
    
    
93. KANG J, Han JK, Ahn Y, Chae SC, et al
    Third-Generation P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre Study.
    Thromb Haemost. 2018;118:591-600.
    PubMed     Abstract available
    
    
    
94. ARIZA-SOLE A, Guerrero C, Formiga F, Aboal J, et al
    Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry.
    Thromb Haemost. 2018;118:581-590.
    PubMed     Abstract available
    
    
    February 2018
95. MJELVA OR, Svingen GFT, Pedersen EKR, Seifert R, et al
    Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease.
    Thromb Haemost. 2018 Feb 19. doi: 10.1055/s-0038-1629912.
    PubMed     Abstract available
    
    
    
96. DE CARVALHO LP, Fong A, Troughton R, Yan BP, et al
    Prognostic Implications of Dual Platelet Reactivity Testing in Acute Coronary Syndrome.
    Thromb Haemost. 2018;118:415-426.
    PubMed     Abstract available
    
    
    
97. STOREY RF, Ardissino D, Vignali L, Cairns R, et al
    Ischaemic Events and Stent Thrombosis following Planned Discontinuation of Study Treatment with Ticagrelor or Clopidogrel in the PLATO Study.
    Thromb Haemost. 2018;118:427-429.
    PubMed    
    
    
    
98. STRATZ C, Nuhrenberg T, Valina CM, Loffelhardt N, et al
    Impact of Reticulated Platelets on the Antiplatelet Effect of the Intravenous P2Y12-Receptor Inhibitor Cangrelor.
    Thromb Haemost. 2018;118:362-368.
    PubMed     Abstract available
    
    
    January 2018
99. VON KANEL R, Meister-Langraf RE, Schmid JP, Barth J, et al
    Low Self-rated Health Is Related to Blood Hypercoagulability in Patients Admitted with Acute Myocardial Infarction.
    Thromb Haemost. 2018;118:54-62.
    PubMed     Abstract available
    
    
    
100. BURNLEY-HALL N, Abdul F, Androshchuk V, Morris K, et al
     Dietary Nitrate Supplementation Reduces Circulating Platelet-Derived Extracellular Vesicles in Coronary Artery Disease Patients on Clopidogrel Therapy: A Randomised, Double-Blind, Placebo-Controlled Study.
     Thromb Haemost. 2018;118:112-122.
     PubMed     Abstract available
     
     
     
101. LOWE GDO
     Self-related Health and Blood Hypercoagulability: A Possible Mechanism for Cardiovascular Risk.
     Thromb Haemost. 2018;118:4-5.
     PubMed    
     
     
     February 2017
102. ZEYMER U, Hohlfeld T, Vom Dahl J, Erbel R, et al
     Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE).
     Thromb Haemost. 2017;117:625-635.
     PubMed     Abstract available
     
     
     
103. CHRISTOPOULOS C, Farag M, Sullivan K, Wellsted D, et al
     Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.
     Thromb Haemost. 2017;117:457-470.
     PubMed     Abstract available
     
     
     
104. BIANCARI F, Brascia D, Onorati F, Reichart D, et al
     Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score.
     Thromb Haemost. 2017;117:445-456.
     PubMed     Abstract available
     
     
     January 2017
105. CHATTERJEE M, Behrendt A, Schmid M, Beck S, et al
     Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.
     Thromb Haemost. 2017;117:311-324.
     PubMed     Abstract available
     
     
     November 2016
106. CHATTERJEE S, Weinberg I, Yeh RW, Chakraborty A, et al
     Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH Score.
     Thromb Haemost. 2016.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: